Cosmos Health Inc.
Healthcare sector | Medical Distribution industry
Metrics for COSM
| Price | $0.36 |
|---|---|
| Shares Outstanding | 52.33M |
| All-Time Low | $0.07 |
| 52-Week Low | $0.28 |
Balance Statement Metrics
| Net Cash / Share | $0 |
|---|---|
| Net Current Assets / Share | $-0.17 |
| Net Tangible Assets / Share | $0.21 |
| Shares Outstanding Ave Change (Annual) | 225.2% |
| Shares Δ YoY | 48.48% |
| Avg CA Burn (Annual %) | -8.00% (as of 4-19-2026) |
| Avg CA Burn (Quarterly %) | 11.14% (as of 4-19-2026) |
Earning Metrics
| Max Earning Power / Share | $-1.6 |
|---|---|
| Adjusted Earning Power |
$-1.85
adjustedEarningPower = (Net Income / EP_MULTIPLIER) / Shares Outstanding
|
| Non-Cash Charges to Market Cap |
1.6%
nonCashChargeToMKTCAP = Non-Cash Charges / Market Capitalization
|
| Avg EBITDA (5Y) | 0 (as of 4-19-2026) |
| Avg EBITDA (5Q) | 0 (as of 4-19-2026) |
| Avg Net Income (5Y) | -14.1M (as of 4-19-2026) |
| Avg Net Income (5Q) | -5.7M (as of 4-19-2026) |
Indicators
| Dividend indicators | Value | Date |
|---|---|---|
| Current Dividend Streak | No | 4-19-2026 |
| Consecutive Years Paid | No | 4-19-2026 |
| Pays Dividend | No | 4-19-2026 |
| Last Dividend Date | 11-20-17 | |
| Income indicators | Value | Date |
|---|---|---|
| EBITDA Positive | No | 4-19-2026 |
| Net Income Positive | No | 4-19-2026 |
| Current Dividend Streak | No | 4-19-2026 |
Metric History Explorer
Pick a metric to view its history table and chart.
Tangible Book Value Per Share History
Formula: Tangible Book Value / shares from balance statements. Includes 6 quarterly + 4 annual.
Chart plots one TBV / Share point per report date (duplicate same-date annual/quarterly rows are merged).
| Report Date | Period | TBV / Share | Tangible Book Value | Shares Used |
|---|---|---|---|---|
| 2025-12-31 | Quarterly | $0.26 | 10.9M ($10,854,934) | 41.1M (41,067,312) |
| 2025-09-30 | Quarterly | $0.48 | 15.2M ($15,174,251) | 31.9M (31,869,041) |
| 2025-06-30 | Quarterly | $0.61 | 18M ($18,006,272) | 29.7M (29,717,802) |
| 2025-03-31 | Quarterly | $0.67 | 18.1M ($18,149,183) | 27.2M (27,198,136) |
| 2024-12-31 | Quarterly | $0.71 | 16.8M ($16,776,395) | 23.6M (23,602,638) |
| 2024-12-31 | Annual | $0.71 | 16.8M ($16,776,395) | 23.6M (23,602,638) |
| 2024-09-30 | Quarterly | $1.17 | 27.2M ($27,229,839) | 23.3M (23,259,526) |
| 2023-12-31 | Annual | $1.78 | 28.2M ($28,235,436) | 15.9M (15,895,975) |
| 2022-12-31 | Annual | $3.64 | 38.6M ($38,577,381) | 10.6M (10,589,915) |
| 2021-12-31 | Annual | $5.67 | 3.9M ($3,893,696) | 686.3K (686,283) |
Revenue History (Annual)
Revenue from income statements. Includes 4 annual.
Chart plots one annual Revenue point per report date.
| Report Date | Revenue |
|---|---|
| 2024-12-31 | 54.4M ($54,426,402) |
| 2023-12-31 | 53.4M ($53,376,874) |
| 2022-12-31 | 50.3M ($50,347,652) |
| 2021-12-31 | 56.2M ($56,239,667) |
Dividend Payments
Historical cash dividends per share from Yahoo ex-dividend dates.
| Date | Dividend / Share |
|---|---|
| No dividend payment history available yet | |
Shares Outstanding Changes
| Date | Shares Outstanding | Delta |
|---|---|---|
| 2026-04-28 | 52,331,231 | +1,506,574 |
| 2026-04-17 | 50,824,657 | +13,478,632 |
| 2026-01-05 | 37,346,025 | +64,301 |
| 2025-12-23 | 37,281,724 | +2,361,804 |
| 2025-11-18 | 34,919,920 | +3,906,044 |
| 2025-09-26 | 31,013,876 | +800,000 |
| 2025-09-18 | 30,213,876 | -24 |
| 2025-08-25 | 30,213,900 | +173,100 |
| 2025-08-19 | 30,040,800 | +799,100 |
Short Interest Changes
Latest short-interest change: 510,079 shares (1.23% of float) | Days to cover: 0.57
| Date | Short Interest | Delta | Δ % |
|---|---|---|---|
| 2026-04-27 | 510,079 shares | +350,260 | +219.16% |
| 2026-04-17 | 159,819 shares | +10,360 | +6.93% |
| 2026-03-24 | 149,459 shares | -186,036 | -55.45% |
| 2026-03-12 | 335,495 shares | +216,000 | +180.76% |
| 2026-02-27 | 119,495 shares | +13,703 | +12.95% |
| 2026-02-11 | 105,792 shares | +52,278 | +97.69% |
Interesting Volume Days
Volume/ratio use shares outstanding as of the event date (frozen).
| Date | Volume | Shares Outstanding | Volume / Shares | Price |
|---|---|---|---|---|
| No interesting volume events | ||||
Cosmos Health Inc. manufactures, develops, and trades branded nutraceutical products in Greece, Croatia, Bulgaria, the United Arab Emirates, the United Kingdom, and Cyprus. The company offers prescription medications, over-the-counter drugs, medical devices, food supplements, nutraceuticals, cosmetics and other healthcare products under the Sky Premium Life and Mediterranation brand names. It also provides ASTO-CHOL (Pravastatin), Diorium (Omeprazole), HEART-FREE (Clopidogrel), LIPICHOL (Atorvastatin), Miltus (Donepezil), Newzypra (Olanzapine), PNEUMO-KAST (Montelukast), Sahar (Pioglitazone), VIVALCID (Leucovorin), and Diabit-is (Sitagliptin). In addition, the company offers branded biocides and antiseptic soaps under the C-Sept and C-Scrub brand names; and other pharmaceutical products include Melatonin Spray, used to reduce insomnia and jet lag; Otikon ear drops, which is a Class II medical device in the form of ear drops; and baby foods, such as organic powder milk, pasta with minced meat, whole grain rice cereals, whole grain cereal porridges, and organic rice creams with vanilla milk, as well as pear, carrot and banana purée under the Bio-bebe brand. It serves wholesalers and retail healthcare providers. Cosmos Health Inc. was incorporated in 2009 and is headquartered in Chicago, Illinois.